Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening.

dc.contributor.authorLadabaum, Uri
dc.contributor.authorFont Marimon, Rebeca
dc.contributor.authorCastells Olivera, Xavier
dc.contributor.authorBalaguer Prunés, Francesc
dc.contributor.authorPellíse, María
dc.contributor.authorSolà, Judit
dc.contributor.authorEspinàs Piñol, Josep Alfons
dc.contributor.authorCastells, Antoni (Castells Oliveres)
dc.date.accessioned2026-03-16T11:43:55Z
dc.date.available2026-03-16T11:43:55Z
dc.date.issued2026-01-30
dc.date.updated2026-02-05T11:15:47Z
dc.description.abstractLong-term adherence and results with faecal immunochemical test (FIT)-based colorectal cancer (CRC) screening are poorly characterised. To characterise adherence and results through seven rounds in an organised biennial FIT-based CRC screening programme. We determined per-round FIT-completion, FIT-positivity, CRC and high-risk-CRC precursor positive predictive values (PPVs) and CRC detection/1000-FIT-participants for all invitees versus an adherent cohort (entry 50-51 years; 66-100% rounds completed) versus comparable-age first-ever screenings from 2010 to 2023. Joinpoint and multivariable logistic regression analyses identified trends. Adherence was consistent, frequent, occasional, infrequent and never (defined as 100%, 66-99%, 33-65%, 1-32%, 0% of rounds offered) in 29.2%, 8.6%, 11.5%, 4.5% and 46.2% of 2.81 million individuals, respectively. In both the all-invitee population and the adherent cohort, the first round yielded the highest FIT positivity (5.8%, 4.4%), PPVs for CRC (5.1%, 3.3%) and high-risk precursors (20.4%, 13.1%), and CRC detection rates (2.65, 1.30 per 1000 participants), respectively. Beyond three rounds, outcomes stabilised at levels substantially lower than those observed in first-time screeners of the same age (eg, CRC-PPV in seventh round: 1.6-2.2% at median age 62-65 vs 6.6% for new screeners aged 62-63). Colonoscopy completion after a positive FIT was high (87.3%). After an initial round with the highest FIT-positivity and detection rates, screening outcomes stabilise at lower levels reflecting neoplasia removal and subsequent selection of a lower-risk population. Because detection rates remain clinically relevant even in an adherent cohort, early screening cessation after a sequence of normal biennial FITs is not justified.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9489868
dc.identifier.issn1468-3288
dc.identifier.pmid41617486
dc.identifier.urihttps://hdl.handle.net/2445/228119
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1136/gutjnl-2025-336994
dc.relation.ispartofGut, 2026
dc.relation.urihttps://doi.org/10.1136/gutjnl-2025-336994
dc.rights(c) Ladabaum, Uri et al., 2026
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationCribratge genètic
dc.subject.classificationCàncer colorectal
dc.subject.otherGenetic screening
dc.subject.otherColorectal cancer
dc.titleEffect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
gutjnl-2025-336994 (1).pdf
Mida:
2.18 MB
Format:
Adobe Portable Document Format